LHLabcorp Holdings Inc.

LH Stock Price, Valuation & Chart | Labcorp Holdings Inc.

Compare

$327.61-5.05 (-1.52%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Equipment & Services LH intrinsic value LH calculated fair value vs price

Overview Financials Dividends Ratios

LH Historical price chart

LH Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization26.86B

PE Ratio19.44

EPS16.85

Trading Volume559.92K

Today's High/Low336.65/326.51

Dividend Yield0.87

52 Week High/Low341.8/244.52

Shares Outstanding82.00M

LH Financial Statement

LH Analyst ratings

LH Analysis & performance metrics

LH Company profile

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The…

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

LH Management team

Name

Position

Akinbolade Oyegunwa M.B.A., Ph.D.CTO

Executive Vice President and Chief Information & Technology Officer

Sandra D. van der Vaart J.D.

Executive Vice President, Chief Legal Officer & Corporate Secretary

Peter J. Wilkinson

Senior Vice President & Chief Accounting Officer

Christin O'Donnell

Vice President of Investor Relations

Adam H. SchechterCEO

President, Chief Executive Officer & Chairman

Amy B. Summy

EVice President, Chief Marketing Officer & Consumer Business Lead

Julia A. WangCFO

Chief Financial Officer & Executive Vice President

Mark S. SchroederCOO

Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer

Name

Position

Akinbolade Oyegunwa M.B.A., Ph.D.CTO

Executive Vice President and Chief Information & Technology Officer

Sandra D. van der Vaart J.D.

Executive Vice President, Chief Legal Officer & Corporate Secretary

Peter J. Wilkinson

Senior Vice President & Chief Accounting Officer

Christin O'Donnell

Vice President of Investor Relations

Adam H. SchechterCEO

President, Chief Executive Officer & Chairman

Amy B. Summy

EVice President, Chief Marketing Officer & Consumer Business Lead

Julia A. WangCFO

Chief Financial Officer & Executive Vice President

Mark S. SchroederCOO

Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer

Management Team

Akinbolade Oyegunwa M.B.A., Ph.D.CTO

Executive Vice President and Chief Information & Technology Officer

Sandra D. van der Vaart J.D.

Executive Vice President, Chief Legal Officer & Corporate Secretary

Peter J. Wilkinson

Senior Vice President & Chief Accounting Officer

Christin O'Donnell

Vice President of Investor Relations

Adam H. SchechterCEO

President, Chief Executive Officer & Chairman

Amy B. Summy

EVice President, Chief Marketing Officer & Consumer Business Lead

Julia A. WangCFO

Chief Financial Officer & Executive Vice President

Mark S. SchroederCOO

Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer

Management

Akinbolade Oyegunwa M.B.A., Ph.D.CTO

Executive Vice President and Chief Information & Technology Officer

Sandra D. van der Vaart J.D.

Executive Vice President, Chief Legal Officer & Corporate Secretary

Peter J. Wilkinson

Senior Vice President & Chief Accounting Officer

Christin O'Donnell

Vice President of Investor Relations

Adam H. SchechterCEO

President, Chief Executive Officer & Chairman

Amy B. Summy

EVice President, Chief Marketing Officer & Consumer Business Lead

Julia A. WangCFO

Chief Financial Officer & Executive Vice President

Mark S. SchroederCOO

Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer

Total 8 executives

LH Frequently asked questions

What is Labcorp Holdings Inc. (LH) Stock Price?

Current stock price of Labcorp Holdings Inc. (LH) stock is $327.61. The stock price is -1.52% lower in the session. The intraday range can be seen from this page. Volume of Labcorp Holdings Inc. (LH) stock is 559.92K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Labcorp Holdings Inc. (LH) stock price going up or down today?

The stock price of Labcorp Holdings Inc. (LH) can change with earnings, company news, and overall market sentiment. Labcorp Holdings Inc. operates in the Healthcare / Medical - Equipment & Services market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Labcorp Holdings Inc. stock expensive at its current price?

Whether Labcorp Holdings Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LH on this page is 19.44. EPS on this page is 16.85. Compare those figures with peers and growth expectations before deciding if the current Labcorp Holdings Inc. price is justified.

How has the stock price of Labcorp Holdings Inc. (LH) performed historically?

Historical performance for Labcorp Holdings Inc. (LH) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LH reacted to past earnings and market events.

Should I buy Labcorp Holdings Inc. (LH) stock, at this price?

Buying Labcorp Holdings Inc. (LH) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.